{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T11:27:56Z","timestamp":1726054076575},"publisher-location":"Cham","reference-count":45,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030259044"},{"type":"electronic","value":"9783030259051"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-25905-1_8","type":"book-chapter","created":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T17:02:41Z","timestamp":1570381361000},"page":"129-147","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hereditary Diseases Predisposing to Pheochromocytoma (VHL, NF-1, Paraganglioma Syndromes, and Novel Genes)"],"prefix":"10.1007","author":[{"given":"Bal\u00e1zs","family":"Sarkadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Pat\u00f3cs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,7]]},"reference":[{"key":"8_CR1","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1126\/science.3107130","volume":"236","author":"D Barker","year":"1987","unstructured":"Barker D, Wright E, Nguyen K et al (1987) Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science 236:1100\u20131102","journal-title":"Science"},{"key":"8_CR2","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1210\/jc.2006-2833","volume":"92","author":"B Bausch","year":"2007","unstructured":"Bausch B, Borozdin W, Mautner VF et al (2007) Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1. J Clin Endocrinol Metab 92:2784\u20132792","journal-title":"J Clin Endocrinol Metab"},{"key":"8_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1530\/ERC-13-0415","volume":"21","author":"B Bausch","year":"2014","unstructured":"Bausch B, Wellner U, Bausch D et al (2014) Long-term prognosis of patients with pediatric pheochromocytoma. Endocr Relat Cancer 21:17\u201325","journal-title":"Endocr Relat Cancer"},{"key":"8_CR4","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1001\/jamaoncol.2017.0223","volume":"3","author":"B Bausch","year":"2017","unstructured":"Bausch B, Schiavi F, Ni Y et al (2017) Clinical characterization of the pheochromocytoma and paraganglioma susceptibility genes SDHA, TMEM127, MAX, and SDHAF2 for gene-informed prevention. JAMA Oncol 3:1204\u20131212","journal-title":"JAMA Oncol"},{"key":"8_CR5","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.287.5454.848","volume":"287","author":"BE Baysal","year":"2000","unstructured":"Baysal BE, Ferrell RE, Willett-Brozick JE et al (2000) Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287:848\u2013851","journal-title":"Science"},{"issue":"23","key":"8_CR6","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1136\/jmedgenet-2018-105714","volume":"126","author":"L Ben Aim","year":"2019","unstructured":"Ben Aim L, Pigny P, Castro-Vega LJ et al (2019) Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paraganglioma. J Med Genet 126(23):1679. \n                    https:\/\/doi.org\/10.1136\/jmedgenet-2018-105714","journal-title":"J Med Genet"},{"key":"8_CR7","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1210\/jc.2005-1862","volume":"91","author":"DE Benn","year":"2006","unstructured":"Benn DE, Gimenez-Roqueplo AP, Reilly JR et al (2006) Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes. J Clin Endocrinol Metab 91:827\u2013836","journal-title":"J Clin Endocrinol Metab"},{"key":"8_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/joim.12507","volume":"280","author":"P Bjorklund","year":"2016","unstructured":"Bjorklund P, Pacak K, Crona J (2016) Precision medicine in pheochromocytoma and paraganglioma: current and future concepts. J Intern Med 280:559\u2013573","journal-title":"J Intern Med"},{"key":"8_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/ng1095-144","volume":"11","author":"T Bourgeron","year":"1995","unstructured":"Bourgeron T, Rustin P, Chretien D et al (1995) Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 11:144\u2013149","journal-title":"Nat Genet"},{"issue":"8","key":"8_CR45","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1158\/0008-5472.CAN-17-2463","volume":"78","author":"A Buffet","year":"2018","unstructured":"Buffet A, Morin A, Castro-Vega LJ, Habarou F, Lussey-Lepoutre C, Letouz\u00e9 E, Lefebvre H, Guilhem I, Haissaguerre M, Raingeard I, Padilla-Girola M, Tran T, Tchara L, Bertherat J, Amar L, Ottolenghi C, Burnichon N, Gimenez-Roqueplo AP, Favier J (2018) Germline mutations in the mitochondrial 2-oxoglutarate\/malate carrier SLC25A11 gene confer a predisposition to metastatic paragangliomas. Cancer Res 78(8):1914\u20131922","journal-title":"Cancer Res"},{"key":"8_CR10","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","volume":"19","author":"N Burnichon","year":"2010","unstructured":"Burnichon N, Briere JJ, Libe R et al (2010) SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 19:3011\u20133020","journal-title":"Hum Mol Genet"},{"key":"8_CR11","doi-asserted-by":"publisher","first-page":"djv053","DOI":"10.1093\/jnci\/djv053","volume":"107","author":"A Cascon","year":"2015","unstructured":"Cascon A, Comino-Mendez I, Curras-Freixes M et al (2015) Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene. J Natl Cancer Inst 107:djv053","journal-title":"J Natl Cancer Inst"},{"key":"8_CR12","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","volume":"23","author":"LJ Castro-Vega","year":"2014","unstructured":"Castro-Vega LJ, Buffet A, De Cubas AA et al (2014) Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas. Hum Mol Genet 23:2440\u20132446","journal-title":"Hum Mol Genet"},{"key":"8_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/humu.1380050109","volume":"5","author":"F Chen","year":"1995","unstructured":"Chen F, Kishida T, Yao M et al (1995) Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat 5:66\u201375","journal-title":"Hum Mutat"},{"key":"8_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1371\/journal.pgen.0010008","volume":"1","author":"PL Dahia","year":"2005","unstructured":"Dahia PL, Ross KN, Wright ME et al (2005) A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet 1:72\u201380","journal-title":"PLoS Genet"},{"key":"8_CR15","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1210\/jcem.86.5.7496","volume":"86","author":"G Eisenhofer","year":"2001","unstructured":"Eisenhofer G, Walther MM, Huynh TT et al (2001) Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. J Clin Endocrinol Metab 86:1999\u20132008","journal-title":"J Clin Endocrinol Metab"},{"key":"8_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/humu.21385","volume":"32","author":"K Frank-Raue","year":"2011","unstructured":"Frank-Raue K, Rybicki LA, Erlic Z et al (2011) Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10. Hum Mutat 32:51\u201358","journal-title":"Hum Mutat"},{"key":"8_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1530\/EJE-09-0399","volume":"161","author":"P Gergics","year":"2009","unstructured":"Gergics P, Patocs A, Toth M et al (2009) Germline VHL gene mutations in Hungarian families with von Hippel-Lindau disease and patients with apparently sporadic unilateral pheochromocytomas. Eur J Endocrinol 161:495\u2013502","journal-title":"Eur J Endocrinol"},{"key":"8_CR18","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1056\/NEJMc1012357","volume":"364","author":"AJ Gill","year":"2011","unstructured":"Gill AJ, Pachter NS, Clarkson A et al (2011) Renal tumors and hereditary pheochromocytoma-paraganglioma syndrome type 4. N Engl J Med 364:885\u2013886","journal-title":"N Engl J Med"},{"key":"8_CR19","first-page":"5615","volume":"63","author":"AP Gimenez-Roqueplo","year":"2003","unstructured":"Gimenez-Roqueplo AP, Favier J, Rustin P et al (2003) Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas. Cancer Res 63:5615\u20135621","journal-title":"Cancer Res"},{"key":"8_CR20","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1126\/science.1175689","volume":"325","author":"HX Hao","year":"2009","unstructured":"Hao HX, Khalimonchuk O, Schraders M et al (2009) SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 325:1139\u20131142","journal-title":"Science"},{"key":"8_CR21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1399-0004.2011.01653.x","volume":"81","author":"E Hensen","year":"2012","unstructured":"Hensen E, Van Duinen N, Jansen J et al (2012) High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands. Clin Genet 81:284\u2013288","journal-title":"Clin Genet"},{"key":"8_CR22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1471-2350-11-92","volume":"11","author":"FJ Hes","year":"2010","unstructured":"Hes FJ, Weiss MM, Woortman SA et al (2010) Low penetrance of a SDHB mutation in a large Dutch paraganglioma family. BMC Med Genet 11:92","journal-title":"BMC Med Genet"},{"key":"8_CR23","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrc885","volume":"2","author":"WG Kaelin Jr","year":"2002","unstructured":"Kaelin WG Jr (2002) Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer 2:673\u2013682","journal-title":"Nat Rev Cancer"},{"key":"8_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1158\/1078-0432.CCR-10-0420","volume":"17","author":"HP Kunst","year":"2011","unstructured":"Kunst HP, Rutten MH, De Monnink JP et al (2011) SDHAF2 (PGL2-SDH5) and hereditary head and neck paraganglioma. Clin Cancer Res 17:247\u2013254","journal-title":"Clin Cancer Res"},{"key":"8_CR25","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G et al (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99:1915\u20131942","journal-title":"J Clin Endocrinol Metab"},{"key":"8_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1210\/en.2013-1549","volume":"155","author":"N Lendvai","year":"2014","unstructured":"Lendvai N, Pawlosky R, Bullova P et al (2014) Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of SDHB\/D-related paraganglioma: initial experimental and ex vivo findings. Endocrinology 155:27\u201332","journal-title":"Endocrinology"},{"key":"8_CR27","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/0016-5085(91)90026-H","volume":"101","author":"HP Neumann","year":"1991","unstructured":"Neumann HP, Dinkel E, Brambs H et al (1991) Pancreatic lesions in the von Hippel-Lindau syndrome. Gastroenterology 101:465\u2013471","journal-title":"Gastroenterology"},{"key":"8_CR28","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1056\/NEJMoa020152","volume":"346","author":"HPH Neumann","year":"2002","unstructured":"Neumann HPH, Bausch B, Mcwhinney SR et al (2002) Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346:1459\u20131466","journal-title":"N Engl J Med"},{"key":"8_CR29","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jama.292.8.943","volume":"292","author":"HP Neumann","year":"2004","unstructured":"Neumann HP, Pawlu C, Peczkowska M et al (2004) Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292:943\u2013951","journal-title":"JAMA"},{"key":"8_CR30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ajhg.2008.07.011","volume":"83","author":"Y Ni","year":"2008","unstructured":"Ni Y, Zbuk KM, Sadler T et al (2008) Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes. Am J Hum Genet 83:261\u2013268","journal-title":"Am J Hum Genet"},{"key":"8_CR31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/81551","volume":"26","author":"S Niemann","year":"2000","unstructured":"Niemann S, Muller U (2000) Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 26:268\u2013270","journal-title":"Nat Genet"},{"key":"8_CR32","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/humu.20385","volume":"28","author":"KR Ong","year":"2007","unstructured":"Ong KR, Woodward ER, Killick P, Lim C, Macdonald F, Maher ER (2007) Genotype-phenotype correlations in von Hippel-Lindau disease. Hum Mutat 28:143\u2013149","journal-title":"Hum Mutat"},{"key":"8_CR33","first-page":"232","volume":"137","author":"F Otsuka","year":"2001","unstructured":"Otsuka F, Kawashima T, Imakado S, Usuki Y, Hon-Mura S (2001) Lisch nodules and skin manifestation in neurofibromatosis type 1. Arch Dermatol 137:232\u2013233","journal-title":"Arch Dermatol"},{"key":"8_CR34","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s12253-016-0050-0","volume":"22","author":"A Patocs","year":"2016","unstructured":"Patocs A, Lendvai NK, Butz H et al (2016) Novel SDHB and TMEM127 mutations in patients with pheochromocytoma\/paraganglioma syndrome. Pathol Oncol Res 22:673\u2013679","journal-title":"Pathol Oncol Res"},{"key":"8_CR35","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0033","volume":"174","author":"PF Plouin","year":"2016","unstructured":"Plouin PF, Amar L, Dekkers OM et al (2016) European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur J Endocrinol 174:G1\u2013g10","journal-title":"Eur J Endocrinol"},{"key":"8_CR36","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1093\/jnci\/djn254","volume":"100","author":"C Ricketts","year":"2008","unstructured":"Ricketts C, Woodward ER, Killick P et al (2008) Germline SDHB mutations and familial renal cell carcinoma. J Natl Cancer Inst 100:1260\u20131262","journal-title":"J Natl Cancer Inst"},{"key":"8_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/humu.21136","volume":"31","author":"CJ Ricketts","year":"2010","unstructured":"Ricketts CJ, Forman JR, Rattenberry E et al (2010) Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Hum Mutat 31:41\u201351","journal-title":"Hum Mutat"},{"key":"8_CR38","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/cge.12591","volume":"89","author":"JA Rijken","year":"2016","unstructured":"Rijken JA, Niemeijer ND, Corssmit EP et al (2016) Low penetrance of paraganglioma and pheochromocytoma in an extended kindred with a germline SDHB exon 3 deletion. Clin Genet 89:128\u2013132","journal-title":"Clin Genet"},{"key":"8_CR39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1556\/650.2018.31036","volume":"159","author":"B Sarkadi","year":"2018","unstructured":"Sarkadi B, Grolmusz VK, Butz H et al (2018) Evolution of molecular genetic methods in the clinical diagnosis of hereditary endocrine tumour syndromes. Orv Hetil 159:285\u2013292","journal-title":"Orv Hetil"},{"key":"8_CR40","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1001\/jama.294.16.2057","volume":"294","author":"F Schiavi","year":"2005","unstructured":"Schiavi F, Boedeker CC, Bausch B et al (2005) Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA 294:2057\u20132063","journal-title":"JAMA"},{"key":"8_CR41","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/humu.21269","volume":"31","author":"F Schiavi","year":"2010","unstructured":"Schiavi F, Milne RL, Anda E et al (2010) Are we overestimating the penetrance of mutations in SDHB? Hum Mutat 31:761\u2013762","journal-title":"Hum Mutat"},{"key":"8_CR42","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1056\/NEJMoa1213507","volume":"368","author":"MD Shirley","year":"2013","unstructured":"Shirley MD, Tang H, Gallione CJ et al (2013) Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med 368:1971\u20131979","journal-title":"N Engl J Med"},{"key":"8_CR43","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1399-0004.2009.01157.x","volume":"75","author":"DC Solis","year":"2009","unstructured":"Solis DC, Burnichon N, Timmers HJLM et al (2009) Penetrance and clinical consequences of a gross SDHB deletion in a large family. Clin Genet 75:354\u2013363","journal-title":"Clin Genet"},{"key":"8_CR44","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.bbabio.2016.03.012","volume":"1857","author":"L Tretter","year":"2016","unstructured":"Tretter L, Patocs A, Chinopoulos C (2016) Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis. Biochim Biophys Acta 1857:1086\u20131101","journal-title":"Biochim Biophys Acta"}],"container-title":["Experientia Supplementum","Genetics of Endocrine Diseases and Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-25905-1_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T17:03:17Z","timestamp":1570381397000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-25905-1_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030259044","9783030259051"],"references-count":45,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-25905-1_8","relation":{},"ISSN":["1664-431X","2504-3692"],"issn-type":[{"type":"print","value":"1664-431X"},{"type":"electronic","value":"2504-3692"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"7 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}